Skip to content
Politically.com Search all
Menu

2025 · 3rd Quarter (July 1 - Sep 30)

PRIME THERAPEUTICS

Filed by PRIME THERAPEUTICS.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 16, 2025
Income
Not reported
Expenses
$100,000.00
Filing UUID
f99af9e3-54ea-4b92-bad8-dd8f2321ce60
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

S. 891, The Bipartisan Health Care Act, provisions related to PBM regulation H.R. 10445 (118th Congress), Further Consolidating Appropriations and Disaster Relief Supplemental Appropriations Act, Division E, Healthcare, provisions regulating pharmacy benefit managers H.R. 2214, The DRUG Act -provisions related to PBM compensation H.R. 5378 (118th Congress), Lower Cost, More Transparency Act S. 526 Pharmacy Benefit Manger Transparency Act of 2025 -provisions related to transparency and pharmacy and PBM compensation S, 1339 PBM Reform Act (118th Congress) provisions related to PBM compensation Draft legislation, Patients Before Middlemen regarding payor ownership of pharmacies General education on ERISA and PBMs

Literal federal measure citations: S. 891, H.R. 10445, H.R. 2214, H.R. 5378, S. 526

MMM · Medicare/Medicaid

S. 891, The Bipartisan Health Care Act, provisions related to PBM regulation S. 891, The Bipartisan Health Care Act, provisions related to PBM regulation H.R. 10445 (118th Congress), Further Consolidating Appropriations and Disaster Relief Supplemental Appropriations Act, Division E, Healthcare, provisions regulating pharmacy benefit managers H.R. 5378 (118th Congress), Lower Cost, More Transparency Act H.R. 4231 Treat and Reduce Obesity Act-provisions related to coverage of obesity medications in Medicare H.R. 4317, PBM Reform Act of 2025 legislation on PBM reform in Medicare and pharmacy access standards

Literal federal measure citations: S. 891, S. 891, H.R. 10445, H.R. 5378, H.R. 4231, H.R. 4317

TRD · Trade (domestic/foreign)

Tariffs on pharmaceuticals.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.